Caribou Biosciences, Inc. (CRBU): Price and Financial Metrics

Caribou Biosciences, Inc. (CRBU): $1.42

0.07 (+5.19%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add CRBU to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#257 of 337

in industry

CRBU Price/Volume Stats

Current price $1.42 52-week high $8.33
Prev. close $1.35 52-week low $1.22
Day low $1.33 Volume 1,655,700
Day high $1.46 Avg. volume 1,450,177
50-day MA $1.63 Dividend yield N/A
200-day MA $2.08 Market Cap 128.59M

CRBU Stock Price Chart Interactive Chart >


Caribou Biosciences, Inc. (CRBU) Company Bio


Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. Caribou Biosciences has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.


CRBU Latest News Stream


Event/Time News Detail
Loading, please wait...

CRBU Latest Social Stream


Loading social stream, please wait...

View Full CRBU Social Stream

CRBU Price Returns

1-mo -7.19%
3-mo -27.55%
6-mo -32.06%
1-year N/A
3-year -85.80%
5-year N/A
YTD -10.69%
2024 -72.25%
2023 -8.76%
2022 -58.38%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!